{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:50:43Z","timestamp":1791906643819,"version":"4.3.4"},"reference-count":27,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid0810.020349","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T18:15:10Z","timestamp":1340820910000},"page":"1124-1132","source":"Crossref","is-referenced-by-count":117,"title":["Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence"],"prefix":"10.3201","volume":"8","author":[{"given":"Colin W.","family":"Shepard","sequence":"first","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montse","family":"Soriano-Gabarro","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Zell","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hayslett","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lukacs","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Factor","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USANew York Academy of Medicine, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Jones","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Ridzon","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Williams","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Rosenstein","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CDC Adverse Events Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2002,10]]},"reference":[{"key":"key-10.3201\/eid0810.020349-201206270400-R1","first-page":"1077","article-title":"Update: investigation of bioterrorism-related anthrax\u2014Connecticut, 2001.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0810.020349-201206270400-R2","first-page":"1008","article-title":"Update: investigation of bioterrorism-related anthrax, 2001.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0810.020349-201206270400-R3","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax.","volume":"167","author":"Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid0810.020349-201206270400-R4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey.","volume":"54","author":"Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"key":"key-10.3201\/eid0810.020349-201206270400-R5","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working group on civilian biodefense.","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"key-10.3201\/eid0810.020349-201206270400-R6","first-page":"55679","article-title":"Prescription drug products; doxycycline and penicillin G Procaine administration for inhalational anthrax (post-exposure).","volume":"66","author":"Food and Drug Administration","year":"2001","journal-title":"Fed Regist"},{"key":"key-10.3201\/eid0810.020349-201206270400-R7","unstructured":"Food and Drug Administration. Medical review. Available from: URL: http:\/\/www.fda.gov\/cder\/foi\/nda\/2000\/19-537S038_cipro.htm. Accessed November 2001."},{"key":"key-10.3201\/eid0810.020349-201206270400-R8","first-page":"95","article-title":"Antimicrobial susceptibility of Bacillus anthracis.","volume":"68","author":"Lightfoot","year":"1990","journal-title":"Salisbury Med Bull"},{"key":"key-10.3201\/eid0810.020349-201206270400-R9","unstructured":"Centers for Disease Control and Prevention. National pharmaceutical stockpile program. Available from: URL: http:\/\/www.cdc.gov\/nceh\/nps\/. Accessed July 3, 2002."},{"key":"key-10.3201\/eid0810.020349-201206270400-R10","unstructured":"Centers for Disease Control and Prevention. Notice to readers: additional options for preventive treatment for persons exposed to inhalational anthrax. MMWR Morb Mortal Wkly Rep 2001;50:1142,1151."},{"key":"key-10.3201\/eid0810.020349-201206270400-R11","first-page":"1051","article-title":"Update: adverse events associated with anthrax prophylaxis among postal employees\u2014New Jersey, New York City, and the District of Columbia Metropolitan Area, 2001.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0810.020349-201206270400-R12","unstructured":"Shepard CW. Adverse events associated with post-exposure antimicrobial prophylaxis for the prevention of anthrax\u2014Florida, New Jersey, New York City, Maryland, Virginia, and Washington, D.C., 2001. In: 51stAnnual Epidemic Intelligence Service Conference program and abstracts book. Atlanta: Centers for Disease Control and Prevention: 2002. p. 51."},{"key":"key-10.3201\/eid0810.020349-201206270400-R13","unstructured":"Physicians Desk Reference. Available from: URL: http:\/\/www.pdrel.com. Accessed July 3, 2002."},{"key":"key-10.3201\/eid0810.020349-201206270400-R14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1086\/515132","article-title":"Safety of long-term therapy with ciprofloxacin: data of controlled clinical trials and review.","volume":"28","author":"Segev","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid0810.020349-201206270400-R15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/j.1875-9114.1987.tb04037.x","article-title":"Increased frequency of doxycycline side effects.","volume":"7","author":"Bryant","year":"1987","journal-title":"Pharmacotherapy"},{"key":"key-10.3201\/eid0810.020349-201206270400-R16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1155\/S1064744998000210","article-title":"Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection.","volume":"6","author":"McCormack","year":"1998","journal-title":"Infect Dis Obstet Gynecol"},{"key":"key-10.3201\/eid0810.020349-201206270400-R17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/jac\/39.4.499","article-title":"Atypical pneumonia in Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline.","volume":"39","author":"Ragnar","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid0810.020349-201206270400-R18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1708-8305.1996.tb00695.x","article-title":"User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis.","volume":"3","author":"Phillips","year":"1996","journal-title":"J Travel Med"},{"key":"key-10.3201\/eid0810.020349-201206270400-R19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archinte.159.2.167","article-title":"Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.","volume":"159","author":"Raoult","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid0810.020349-201206270400-R20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1708-8305.1998.tb00476.x","article-title":"Doxycycline as first line malarial prophylaxis: how safe is it?","volume":"5","author":"Schuhwerk","year":"1998","journal-title":"J Travel Med"},{"key":"key-10.3201\/eid0810.020349-201206270400-R21","unstructured":"Jefferds MD, Roy S, Hayslett J, Frye A, Laserson K, Schuchat A, Promoting postal workers\u2019 adherence to antibiotic prophylaxis to prevent inhalational anthrax\u2014 Washington, DC, 2001. In: 51stAnnual Epidemic Intelligence Service Conference program and abstracts book. Atlanta: Centers for Disease Control and Prevention: 2002. p. 73."},{"key":"key-10.3201\/eid0810.020349-201206270400-R22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1001\/jama.287.5.622","article-title":"Nonspecific medication side effects and the nocebo phenomenon.","volume":"287","author":"Barsky","year":"2002","journal-title":"JAMA"},{"key":"key-10.3201\/eid0810.020349-201206270400-R23","first-page":"987","article-title":"Notice to readers: interim guidelines for investigation of and response to Bacillus anthracis exposures.","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid0810.020349-201206270400-R24","doi-asserted-by":"publisher","first-page":"103S","DOI":"10.1016\/0732-8893(92)90136-H","article-title":"Factors affecting nonadherence with antibiotics.","volume":"15","author":"Sanson-Fisher","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.3201\/eid0810.020349-201206270400-R25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00063110-200109000-00004","article-title":"Adherence to antibiotics prescribed in an accident and emergency department: the influence of consultation factors.","volume":"8","author":"Lam","year":"2001","journal-title":"Eur J Emerg Med"},{"key":"key-10.3201\/eid0810.020349-201206270400-R26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.2105\/AJPH.82.12.1607","article-title":"Correlates of nonadherence to hypertension treatment in an inner-city minority population.","volume":"82","author":"Shea","year":"1992","journal-title":"Am J Public Health"},{"key":"key-10.3201\/eid0810.020349-201206270400-R27","first-page":"264","article-title":"Patient compliance\u2014don\u2019t count on it!","volume":"64","author":"Trick","year":"1993","journal-title":"J Am Optom Assoc"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/8\/10\/02-0349_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:41:49Z","timestamp":1732588909000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/8\/10\/02-0349_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2002,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid0810.020349","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}